The most useful question about Maven Clinic is not simply whether it offers GLP-1 prescriptions. Its public documentation says it does. The harder question is what you would actually be buying: a membership supporting assessment and ongoing care, a separately billed prescription, or additional services outside the initial care team. For someone drawn to Maven’s emphasis on hormonal history and life stage, understanding those boundaries matters as much as the advertised first-month price.
This review examines Maven’s public documentation consulted October 19, 2026, with practical questions for prospective U.S. patients. Maven describes a self-pay consumer GLP-1 program alongside employer-sponsored family benefits and a separate hormone-care offering. Those are not interchangeable payment arrangements. The pages explain several meaningful features, but do not establish a complete state availability list, all additional charges or full cancellation terms. The goal here is to help you prepare for enrollment and consultation—not determine whether a medication is appropriate for you.
At a glance
- Membership is separate from medication
- Maven advertises a $39 first month and $150 per month afterward. The membership fee is not covered by insurance; medication is billed separately by the pharmacy.Sources: [8]
- Lower membership rates require prepayment
- Options are $297 every three months, $534 every six months or $888 every 12 months, advertised as monthly equivalents of $99, $89 and $74.Sources: [8]
- Brand-name medication policy
- Maven says it prescribes FDA-approved products including Wegovy, Ozempic, Zepbound and Foundayo, and does not offer compounded formulations.Sources: [9]
- Included support has boundaries
- The first nutrition and strength consultations are included. Unlimited visits are restricted to the initial GLP-1 care team, while broader network services may cost extra.
Which Maven service are you actually joining?
Start by identifying the program rather than relying on the Maven name alone. The homepage labels GLP-1 Care as “Maven Consumer, self pay,” with access to brand-name prescriptions, metabolic and hormone-health specialists, and nutrition and strength support. Elsewhere, Maven describes family benefits, including maternity and newborn care, as free for members covered through an employer or health plan. That benefit language does not establish that the consumer GLP-1 membership is free or included in your workplace coverage.
Maven also advertises global care, coverage and reimbursement across more than 175 countries for its broader platform. That is not a GLP-1 prescribing map. The GLP-1 pricing page instead says services and prescribing vary by location, availability and applicable law. The consulted pages do not name every eligible state or country. Ask whether assessment, prescribing and follow-up are available where you will physically receive care, rather than treating the platform’s international reach as confirmation.
There is also an access-timing question: the pages contain both enrollment and waitlist language, which does not establish immediate appointments in a particular location. Before paying, ask whether you can book now, which clinical entity will provide care and what credentials your clinician holds. The consulted documentation does not identify individual licenses or all contracting entities. Our guide to questions before joining a GLP-1 program can help organize that first exchange.
What would you pay first—and at the next billing date?
Maven’s pricing page makes an important distinction: the membership pays for visits and care involved in obtaining and continuing a prescription, not the medication itself. The advertised introductory membership is $39 for the first month, followed by $150 per month on the monthly option. Lower monthly equivalents are available through optional prepayment. They are alternatives to monthly billing, not a requirement to buy a year of care, and none includes the pharmacy’s medication charge.
The prepaid choices change the amount collected at each billing interval. Maven states that the first month is always $39, but the consulted documentation does not explain precisely how that introductory month connects to the start of a prepaid term. Ask for the first charge, the next charge date and the amount due then in writing. A three-, six- or 12-month billing arrangement does not by itself establish medication quantity, treatment duration or a minimum clinical commitment.
The membership fee is expressly not covered by insurance. Additional visits, laboratory work or services outside the initial team could also affect your total, and complete prices for those items are not documented here. Before choosing a longer billing interval, separate known membership charges from medication estimates and unpriced services. These questions beyond the monthly price are particularly useful when a low monthly equivalent requires a larger payment.
| Membership option | Advertised amount | Billing detail |
|---|---|---|
| Monthly | $39 first month; $150 per month afterward | Monthly option; introductory-to-prepaid timing is not explained |
| Three months | $99 monthly equivalent | $297 billed every three months |
| Six months | $89 monthly equivalent | $534 billed every six months |
| Twelve months | $74 monthly equivalent | $888 billed every 12 months |
Which medication and presentation does the price describe?
Maven says it prescribes only FDA-approved GLP-1 medications and does not offer compounded formulations. Its list includes semaglutide under Wegovy and Ozempic, tirzepatide under Zepbound, and orforglipron under Foundayo. This is Maven’s description of its offering, not an independent verification of what any individual receives. FDA approval concerns a particular product; it is not approval of Maven as a clinic. Ask for the exact product, presentation and intended use before treating a price as relevant to your situation.
The medication table advertises self-pay prices starting at $149 per month for Wegovy pills, $199 for Wegovy autoinjector pens, $299 for Zepbound KwikPen and $149 for Foundayo pills. It also lists Zepbound vials starting at $299, but that entry inconsistently labels the presentation “Autoinjector pen” as well. Each entry advertises an insured price starting as low as $25 per month. These are conditional minimums, not interchangeable products or guaranteed pharmacy quotes.
Ozempic pens are advertised from $199 per month, with the detailed 0.25 mg listing describing a new-patient introduction through December 31, 2026, then $349 per month. That presentation detail identifies the offer, not dosing advice. Maven also says some medications must be refilled within 45 days of the last order to retain the best available pricing; that is a manufacturer pricing condition, not delivery timing. Use these medication-identification questions to clarify the exact offer and its restrictions.
What should you prepare for the clinical assessment?
Maven’s assessment is explicitly framed around more than a weight entry. It asks about hormonal history, life stage and conditions such as PCOS or perimenopause. Maven says a licensed clinician reviews that assessment before the first visit. For someone seeking a conversation connecting metabolic concerns with reproductive or hormonal history, that is a documented feature worth asking about. It does not establish that every visit is with a physician or that a particular diagnosis leads to a prescription.
The eligibility explanation names BMI, medical history and existing conditions, and says laboratory testing or previous medical records may be required depending on history and location. The consulted pages do not provide a minimum age or specific BMI thresholds for this program. Ask what records to gather, whether testing is needed before a decision and who pays for it. A completed questionnaire or purchased membership should not be interpreted as guaranteed eligibility or a guaranteed prescription.
If GLP-1 treatment is not appropriate, Maven says it can help develop another plan that might involve hormones or other options. Clarify whether that discussion is included and whether a different program carries a separate charge. For consultation preparation, NIDDK advises discussing current medicines, supplements, allergies and pregnancy plans with the treating clinician. Those topics help inform an individual assessment; this review cannot determine eligibility or recommend starting, stopping or adjusting treatment.
Who handles insurance, dispensing and delivery?
Maven says insurance advocates help patients understand benefits and explore potential coverage before starting. If medication is not covered, self-pay pricing is available. Its FAQ says coverage is often more common for type 2 diabetes than for weight management and depends on the plan. Ask whether the quoted price reflects your actual coverage, the exact prescribed product and any applicable offer conditions. Advocacy is useful assistance, but it is not an insurer’s promise to pay or a guarantee of a $25 prescription.
The care pathway says prescriptions go to your pharmacy, with direct-to-home shipping available for select medications. Medication costs are billed separately by the pharmacy according to drug and dose. The consulted documentation does not identify every dispensing pharmacy, explain which products qualify for direct shipment or establish shipping fees and arrival times. Ask who dispenses the prescription, how payment is collected and which organization resolves a missing or delayed order before you assume Maven controls the entire process.
For an injectable shipment, ask the dispensing pharmacy about storage requirements and whom to contact if the delivery seems compromised. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and contacting the provider or pharmacy. That is general handling guidance, not evidence of a Maven delivery problem. The public pages do not document Maven-specific cold-chain procedures or promise that a dispatch date will be the date medication reaches your home.
What does ongoing support include in practice?
Maven describes follow-up through messaging and scheduled video calls, along with symptom and progress tracking visible to the full care team. It also lists side-effect management and personalized weight and metabolic insights. Those are meaningful service descriptions, but “anytime” messaging or scheduling does not establish an immediate response or around-the-clock live clinical coverage. Ask which channel handles routine questions, what response window applies and how to seek help when the usual team is unavailable.
The first nutrition and strength consultations are included, and additional visits can be booked as care evolves. Broader access to Maven’s full provider network is described as pay-as-you-go. The pricing footnote further restricts unlimited visits to the initial GLP-1 care team, while leaving that team’s composition unfinished as “[xxx].” Consequently, the public language does not support assuming unlimited appointments with every specialist. Request the included professions, visit types and additional-visit prices before relying on the headline.
Follow-up should also be distinguished from simply renewing a subscription. NIDDK describes medication follow-up as attention to tolerance and response, with duration depending on benefits and side effects. Maven says treatment duration is personal rather than prescribing one fixed timeline. Ask how its team reviews progress and discusses continuation or a change in approach. Our guide to support after the first prescription can help turn those broad promises into concrete questions about responsibility and access.
Is hormone care included or a different purchase?
Maven’s hormonal-health emphasis can make its offerings sound closely connected, but Hormone Care Essentials has a separate documented payment model. It costs $150 as a one-time payment with no subscription and includes two 20-minute consultations plus up to 20 messages. Additional visits are charged separately, and medication is excluded. Do not read that package as the GLP-1 membership’s visit allowance, or assume a GLP-1 payment automatically purchases this separate hormone-care service.
The hormone-care pages list birth control, vaginal estrogen, estrogen-only therapy and combined estrogen and progesterone, with the latter prescribed separately. They also describe nonhormonal options including SSRIs/SNRIs, gabapentin and medications for incontinence when clinically appropriate. These are descriptions of a separate service’s prescribing scope, not recommendations or evidence that every option fits a particular patient. Ask which program is responsible if your consultation raises both metabolic concerns and symptoms addressed by hormone care.
For Hormone Care, Maven says the one-time service fee is not covered by insurance, although prescriptions may be covered and are sent to the preferred pharmacy for coverage processing. Virtual visits are intended for consultation and follow-up; the clinician can direct patients toward in-person care or additional testing when needed. These boundaries are helpful, but they do not establish that outside testing or referrals are included in the fee. Obtain a separate cost explanation if both programs are proposed.
What remains unresolved before you commit?
The most consequential contractual gap concerns what happens after payment. Maven says patients may qualify for a refund if a clinician determines GLP-1 treatment is not a fit, referring readers to Payment Terms & Conditions. Those complete terms were not available in the consulted text. “May qualify” is not an automatic refund promise. Ask which payment is refundable, what exclusions apply, how to request a review and whether a prepaid balance is treated differently from the introductory membership charge.
The consulted documentation also does not establish full automatic-renewal rules, cancellation notice requirements or refunds for unused prepaid periods. Do not infer those rights from the ability to choose a monthly plan or from a package’s duration. Before authorizing payment, obtain the current terms and ask when cancellation becomes effective, whether further charges can occur and what happens to access or pending prescriptions. If the answers are unclear, the lower prepaid equivalent is not enough information to evaluate the commitment.
Finally, distinguish the service description from evidence of outcomes. The reviewed pages document Maven’s care model, not a measured patient-specific result. Maven itself notes that prescribing may be off-label and that medications carry risks, including serious side effects. Its marketing does not establish how you will respond. A useful final conversation should connect the exact product, clinical rationale, monitoring plan and financial obligations, rather than treating access to a prescription as the only decision that matters.
Questions & answers
Does Maven’s $39 first month include the medication?
No. The $39 introductory price is for membership. Maven says medication is billed separately by the pharmacy according to the drug and dose. The monthly membership becomes $150 afterward unless another billing option is selected. Ask for both the membership charge and the pharmacy estimate before treating either advertised number as your total.
Can I pay $74 each month without prepaying?
That is not the advertised arrangement. The $74 figure is a monthly equivalent for a plan billed at $888 every 12 months. Maven also offers shorter prepaid intervals and a monthly option. Its statement that the first month is always $39 leaves the transition to prepaid billing insufficiently explained, so confirm the payment schedule.
Does having Maven through work mean GLP-1 Care is covered?
Not necessarily. Maven distinguishes consumer self-pay GLP-1 Care from employer- or health-plan-covered family benefits. The GLP-1 membership fee is expressly not covered by insurance. Ask your benefits administrator and Maven about your specific arrangement, then separately verify medication coverage with your health plan rather than assuming platform access includes every service.
Will Maven send medication directly to my home?
Possibly, but not for every medication. Maven says prescriptions are sent to your pharmacy or shipped directly for select medications. The consulted pages do not confirm which products qualify, delivery charges or arrival timelines. Confirm the dispensing pharmacy and delivery arrangement for your actual prescription, rather than assuming all orders use the same fulfillment process.
Are all specialist visits included in membership?
No blanket inclusion is documented. Maven includes the first nutrition and strength consultations, describes broader provider-network access as pay-as-you-go and limits unlimited visits to the initial GLP-1 team. That team is not fully identified in the pricing footnote. Ask for a written list of included clinicians and services, plus charges for additional appointments.
Do I automatically get a refund if I am not prescribed a GLP-1?
No automatic refund is promised in the consulted wording. Maven says you may qualify if the clinician determines GLP-1 treatment is not appropriate, and directs readers to separate payment terms. Obtain those current terms before paying, including which charges are eligible and how requests work. That conditional policy also does not establish general cancellation or prepaid-refund rights.
Our assessment
Maven documents a distinctive proposition: virtual GLP-1 care that explicitly considers hormonal history and life stage, with nutrition and strength consultations included at the start. Its separation of membership from pharmacy billing is clear, and its product-specific price listings offer more detail than a single headline medication price. The practical weaknesses are unresolved boundaries: exact geographic access, the composition of the initial care team, additional service charges and complete cancellation or refund terms. Prospective patients should request a location-specific access answer, an itemized payment schedule and the current payment terms before enrolling—especially before prepaying. Maven’s documented model provides useful material for a consultation, but neither the introductory price nor the broader platform’s reach substitutes for those answers.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Maven Clinic — hormone care/pricing ↗
- Maven Clinic — glp 1 care ↗
- Maven Clinic — glp 1 care/how it works ↗
- Maven Clinic — official website ↗
- Maven Clinic — hormone care/faq ↗
- Maven Clinic — glp 1 care/pricing ↗
- Maven Clinic — glp 1 care/faq ↗